Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RORY DRAY BRIENEN

Eye and Vision Services Providers Optometrist

NPI
1194757377
CMS profile
281121
Location
NAPLES, FL

General Payments · PY2018–2024

$1,752.11

  • Reported across 51 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$621.60

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $621.60 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BIOTISSUE HOLDINGS INC. $316.24 2
ABBVIE INC. $223.15 9
Bausch & Lomb Americas Inc. $35.43 2
Dompe US, Inc. $28.49 1
Alcon Laboratories Inc $18.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $301.89 3
PY2019 $104.79 1
PY2020 $16.53 1
PY2021 $245.63 6
PY2022 $159.32 8
PY2023 $302.35 17
PY2024 $621.60 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $32.24 02/15/2024 Food and Beverage Undisputed 01/23/2026 1103368273 CMS
ABBVIE INC. $32.64 03/22/2024 Food and Beverage Undisputed 01/23/2026 1103368275 CMS
ABBVIE INC. $33.73 05/02/2024 Food and Beverage Undisputed 01/23/2026 1103368277 CMS
ABBVIE INC. $15.30 05/09/2024 Food and Beverage Undisputed 01/23/2026 1103368279 CMS
ABBVIE INC. $28.77 06/27/2024 Food and Beverage Undisputed 01/23/2026 1103368281 CMS
ABBVIE INC. $19.36 07/19/2024 Food and Beverage Undisputed 01/23/2026 1103368283 CMS
ABBVIE INC. $25.74 07/25/2024 Food and Beverage Undisputed 01/23/2026 1103368285 CMS
ABBVIE INC. $18.28 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103368287 CMS
ABBVIE INC. $17.09 10/18/2024 Food and Beverage Undisputed 01/23/2026 1103368289 CMS
Alcon Vision LLC $18.29 03/21/2024 Food and Beverage Undisputed 01/23/2026 1110702354 CMS
Bausch & Lomb Americas Inc. $19.18 05/14/2024 Food and Beverage Undisputed 01/23/2026 1140438466 CMS
Bausch & Lomb Americas Inc. $16.25 09/24/2024 Food and Beverage Undisputed 01/23/2026 1140438464 CMS
BIOTISSUE HOLDINGS INC. $158.12 10/17/2024 Food and Beverage Undisputed 01/23/2026 1148753210 CMS
BIOTISSUE HOLDINGS INC. $158.12 11/25/2024 Food and Beverage Undisputed 01/23/2026 1148786223 CMS
Dompe US, Inc. $28.49 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151414727 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.